Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.88 EUR
−11.01 M EUR
106.34 M EUR
3.75 M
About DR HOENLE AG
Sector
Industry
CEO
Markus Arendt
Website
Headquarters
Gilching
Founded
1976
ISIN
DE0005157101
FIGI
BBG000F69TC3
Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet products. It operates through the following segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment offers UV products that are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Adhesives segment develops, produces, and sells adhesives. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The company was founded by Karl Hönle and Günter Schmid in 1976 and is headquartered in Gilching, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HNL is 9.00 EUR — it has decreased by −0.44% in the past 24 hours. Watch DR HOENLE AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange DR HOENLE AG stocks are traded under the ticker HNL.
HNL stock has fallen by −3.64% compared to the previous week, the month change is a −21.40% fall, over the last year DR HOENLE AG has showed a −50.82% decrease.
We've gathered analysts' opinions on DR HOENLE AG future price: according to them, HNL price has a max estimate of 26.50 EUR and a min estimate of 19.00 EUR. Watch HNL chart and read a more detailed DR HOENLE AG stock forecast: see what analysts think of DR HOENLE AG and suggest that you do with its stocks.
HNL stock is 2.25% volatile and has beta coefficient of 0.32. Track DR HOENLE AG stock price on the chart and check out the list of the most volatile stocks — is DR HOENLE AG there?
Today DR HOENLE AG has the market capitalization of 54.56 M, it has decreased by −5.15% over the last week.
Yes, you can track DR HOENLE AG financials in yearly and quarterly reports right on TradingView.
DR HOENLE AG is going to release the next earnings report on Dec 6, 2024. Keep track of upcoming events with our Earnings Calendar.
HNL net income for the last quarter is −265.00 K EUR, while the quarter before that showed 181.00 K EUR of net income which accounts for −246.41% change. Track more DR HOENLE AG financial stats to get the full picture.
As of Nov 10, 2024, the company has 594.00 employees. See our rating of the largest employees — is DR HOENLE AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR HOENLE AG EBITDA is 6.82 M EUR, and current EBITDA margin is −0.77%. See more stats in DR HOENLE AG financial statements.
Like other stocks, HNL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR HOENLE AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR HOENLE AG technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR HOENLE AG stock shows the sell signal. See more of DR HOENLE AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.